In Cuba the anticovid booster vaccination began for children aged

In Cuba, the anticovid booster vaccination began for children aged two to eleven years

The aim of the new campaign is to reach the entire population of these age groups before the start of the next school year

During the mass pediatric vaccination campaign, conducted between September and November 2021, more than 1,800,000 children and adolescents between the ages of two and 18 were vaccinated. (Photo: ACN)



The anti-Covid booster vaccination for children between the ages of two and eleven began this Wednesday in the province of Cienfuegos and is later to be extended to the rest of the country, according to a report by National Television News.

On July 19, at a meeting of the temporary working group to combat the pandemic, headed by the First Party Secretary and President of the Republic, Miguel Díaz-Canel Bermúdez, it was decided to start administering the first booster vaccination to the age group between two and 11 years and 11 months with the Sovereign Plus vaccine, owned by the Finlay Vaccine Institute (IFV).

The new campaign aims to reach all populations in these age groups before the start of the next school year in September, while those recovering from the disease and those allergic to thiomersal also receive the boost, the said Report.

More than 1,800,000 children were vaccinated during the mass immunization campaign of pediatric age against SARS-COV-2, carried out between September and November 2021 with the vaccines Soberana 02 and Soberana Plus, the first of its kind in the world , girls and adolescents between two and 18 years.

The 12-18 year vaccine-eligible age group, comprising approximately 840,000 minors, was already eligible for the booster dose and was more than 50 percent complete as of May 2022.

According to recent statements by ifv investigator Dagmar García Rivera to Prensa Latina, the childhood vaccination campaign has demonstrated the safety of the Cuban product, since more than five million doses have been administered, with no reports of serious side effects described by the WHO. of particular interest and appeared with other vaccine platforms.